15例胃间质瘤临床病理分析

近年来，许多学者通过免疫组化及超微结构对胃肠间质瘤（gastrointestinal stromal tumor，GIST）进行研究。我院近8年来收治15例胃间质瘤，现将其临床病理特点分析报告如下。     

Gaucher disease: abdominal MR imaging findings in 46 patients.

Abdominal magnetic resonance imaging findings were reviewed in 46 patients with Gaucher disease. All patients had hepatosplenomegaly at the time of initial imaging. Splenic nodules were present in 14 patients (30%) and varied in signal intensity. These nodules were isointense on T1-weighted and hypointense on T2-weighted images. Splenic infarcts were seen in 15 patients (33%), and four of these patients (9%) also had subcapsular fluid collections. Both nodules and infarcts were present in the spleen in four patients (9%). Pathologic correlation was performed with specimens from two patients who underwent partial splenectomy. Focal areas of abnormal signal intensity were noted in the liver in nine patients (20%). They were either stellate or segmental, and may represent fibrotic septa with ischemic changes associated with aggregates of Gaucher cells. No changes were noted in the kidneys or abdominal lymph nodes.     

Outcome study: comparison of short-term vs long-term treatment in a residential community.

All patients admitted to a Residential Treatment Center (RTC), a drug-free hospital-based inpatient facility in February 1985 through July 1985, were followed-up 6 months after discharge. The results are contrasted with those obtained in 1973 in a similar follow-up study. Length of stay at RTC had been reduced from 1 year in 1973 to 3 months in 1985. Six months after discharge, the longer length of stay in 1973 appears to be almost twice as effective as the 3-month program in 1985.     

K562／ADM耐药细胞株的建立及其生物学特性的初步观察

我们建立的K562/ADM耐药细胞株,在ADM浓度为2.4μg/m1(4.46μM)中已稳定培养3.5个月,传了30—35代,K562/ADM亦具有多药耐受件(Multidrug Resistance,MDR)的特点,对ADM、VCR、AT—1258和DDP的耐受性分别为K562的114.7、94.0、13.3和7.4倍,但对5—FU不产生交叉耐药。K562和K562/ADM的倍增时间分别为19.2h和52.8h,集落生成率分别为37.5％和11.1％,K562染色体数为34—68,中位数为56;K562/MDM染色体数为32—90,中位数为50,K562/ADM可做为耐药机理和克服耐药措施研究的极好模型。     

急非淋白血病完全缓解后巩固治疗的对照研究

目的探讨急非淋白血病完全缓解后巩固治疗与缓解期的关系。方法对３０例坚持与未坚持完全缓解后巩固化疗的急非淋患者（每组１５例）进行对照研究。比较两组患者的完全缓解期。结果两组患者入院时情况、治疗及达完全缓解时间经统计学处理无明显差异（Ｐ＞０．０５）；而坚持巩固化疗组平均持续完全缓解期（１９．８ｍｏ）明显长于对照组（８．４ｍｏ），统计学具有显著差异（Ｐ＜０．０１）。结论急非淋白血病达完全缓解后，坚持骨髓抑制性治疗对延长完全缓解期以达长期生存目的具有重要意义。     

APPLICATION OF ACUPOINT-INJECTION THERAPY TO PAIN SYNDROME: CLINICAL ANALYSIS OF 250 CASES

In this paper,250 cases of headache,shoulder pain,lumbago and leg pain weretreated with 20％Angelicae Sinensis mixed with Vitamine B_(12) point-injection therapy.The total effective rate was 95.2％and in which the cure rate was 53.6％.Authors have found a close correlation between the effectiveness and the duration of disease.     

阶跃切应力对内皮细胞释放前列环素的影响

采用流室定量研究阶跃切应力对内皮细胞释放前列环素（ｐＧＩ＿２）的影响。对流室中的内皮细胞连续１００分钟施加１、１０、２０ｄｙｎｅ／ｃｍ￣２的阶跃剪切应力，用放免法测流室的８个时间段流出液的６－ｋｅｔｏ－ＰＧＦｉ＿（１ａ）。绘出切应力刺激内皮细胞释放ＰＧＩ＿２的曲线。结果表明：未施加切应力时，内皮细胞释放ＰＧＩ＿２的量在检测限以下，施加切应力后，ＰＧＩ＿２释放速率很快达极大值，且又在数分钟内减小．施加阶跃切应力越大，ＰＧＩ＿２释放速率曲线峰值越高，但衰减也越快，在８０～１００分钟时间内的前列环素释放速率平均值也越大。由此提示，在活体中血液流变学因素一血流切应力对血管内皮细胞释放前列环素有促进作用。     

Survival following hydrofluoric acid ingestion.

Systemic toxicity after significant dermal exposure to hydrofluoric acid includes rapid development of hypocalcemia and hyperkalemia, leading to ventricular fibrillation. Similar dysrhythmias have occurred in patients after ingestion of sodium fluoride-containing compounds. Ingestion of hydrofluoric acid could induce similar cardiac toxicity; however, reported cases of hydrofluoric acid ingestion rarely have been described, and the rapid death of these patients has not allowed verification of this hypothesis. On two separate occasions, a 70-year-old woman ingested up to 2 oz of a 8% hydrofluoric acid-containing solution. Recurrent ventricular fibrillation with concurrent hypocalcemia and hypomagnesemia complicated her first episode, whereas a more aggressive administration of calcium and magnesium may have prevented dysrhythmias in the second episode. Survival from ventricular fibrillation after hydrofluoric acid ingestion has not been reported previously and suggests a role for aggressive empiric calcium and magnesium replacement.     

青光眼小梁切除术后浅前房临床分析

目的 探讨青光眼小梁切除术后浅前房的原因及发生情况。方法 回顾总结我院1997年1月至2001年12月连续92例104只眼小梁切除术后发生浅前房的程度及原因。结果 本组发生术后浅前房16眼；占15.4％，其中结膜漏1眼(6．25％)，滤过过强11眼(68．75％)，脉络膜睫状体脱离4眼(25％)。结论 青光眼小梁切除术后浅前房原因复杂，与术前眼压关系密切，与患者年龄及青光眼类型无关，最常见的原因是房水滤过过强。